Research Papers

25 of 2264 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Morphine- and foot shock-responsive neuronal ensembles in the VTA possess different connectivity and biased GPCR signal…
Wang F; Liu CB; Wang Y; Wang XX; Yang YY; Jiang CY; Le QM; Liu X; Ma L; Wang FF.
Theranostics (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Copper incorporated biomaterial-based technologies for multifunctional wound repair.
Zhang Z; Xue H; Xiong Y; Geng Y; Panayi AC; Knoedler S; Dai G; Shahbazi MA; Mi B; Liu G.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Inactivation of the NLRP3 inflammasome mediates exosome-based prevention of atrial fibrillation.
Parent S; Vaka R; St Amant J; Kahn S; Van Remortel S; Bi C; Courtman D; Stewart DJ; Davis DR.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Annotation of CD8<sup>+</sup> T-cell function via ICAM-1 imaging identifies FAK inhibition as an adjuvant to augment th…
Zhang T; Zhang Y; Zhao Y; Song R; Wang Y; Li K; Zhou H; Wang F; Zhou S; Zhao M; Zhu H; Zhang W; Yang Z; Liu Z.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma.
Liu S; Qin Z; Mao Y; Wang N; Zhang W; Wang Y; Chen Y; Jia L; Peng X.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Initial IL-10 production dominates the therapy of mesenchymal stem cell scaffold in spinal cord injury.
Yang L; Cao J; Du Y; Zhang X; Hong W; Peng B; Wu J; Weng Q; Wang J; Gao J.
Theranostics (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Long-term Nephrotoxicity after PRRT: Myth or Reality.
Baum RP; Fan X; Jakobsson V; Yu F; Schuchardt C; Chen X; Zhang J.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Current evidence and therapeutic implication of PANoptosis in cancer.
Ocansey DKW; Qian F; Cai P; Ocansey S; Amoah S; Qian Y; Mao F.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Engineered bacterial outer membrane vesicles: a versatile bacteria-based weapon against gastrointestinal tumors.
Zheng K; Feng Y; Li L; Kong F; Gao J; Kong X.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape.
Li X; Qi J; Wang J; Hu W; Zhou W; Wang Y; Li T.
Theranostics (Unknown)
Published: 2024
2/6 Transparent
Human organoids-on-chips for biomedical research and applications.
Wang H; Ning X; Zhao F; Zhao H; Li D.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squa…
Kang SH; Oh SY; Lee KY; Lee HJ; Kim MS; Kwon TG; Kim JW; Lee ST; Choi SY; Hong SH.
Theranostics (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Tumor-tropic Trojan horses: Using mesenchymal stem cells as cellular nanotheranostics.
Rosu A; Ghaemi B; Bulte JWM; Shakeri-Zadeh A.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Lower-grade gliomas surgery guided by GRPR-targeting PET/NIR dual-modality image probe: a prospective and single-arm cl…
Chen L; Zhang J; Chi C; Che W; Dong G; Wang J; Du Y; Wang R; Zhu Z; Tian J; Ji N; Chen X; Li D.
Theranostics (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Fibroblast-derived extracellular vesicles as trackable efficient transporters of an experimental nanodrug with fibrotic…
RuizdelRio J; Guedes G; Novillo D; Lecue E; Palanca A; Cortajarena AL; Villar AV.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The LMIT: Light-mediated minimally-invasive theranostics in oncology.
Fan Y; Liu S; Gao E; Guo R; Dong G; Li Y; Gao T; Tang X; Liao H.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma.
Qin LN; Zhang H; Li QQ; Wu T; Cheng SB; Wang KW; Shi Y; Ren HR; Xing XW; Yang C; Sun T.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Tumor-on-a-chip models combined with mini-tissues or organoids for engineering tumor tissues.
Hwangbo H; Chae S; Kim W; Jo S; Kim GH.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Reprogramming Exosomes to Escape from Immune Surveillance for Mitochondrial Protection in Hepatic Ischemia-Reperfusion …
Liu S; Xiao X; Zhang; Wang J; Zhao W; Liu H; Liao R; Li Z; Xu M; Guo J; Zhou B; Du C; Peng Q; Jiang N.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Lymphatic vessels: roles and potential therapeutic intervention in rheumatoid arthritis and osteoarthritis.
Zhou S; Zhao G; Chen R; Li Y; Huang J; Kuang L; Zhang D; Li Z; Xu H; Xiang W; Xie Y; Chen L; Ni Z.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Neutrophil-like pH-responsive pro-efferocytic nanoparticles improve neurological recovery by promoting erythrophagocyto…
Fan L; Jin L; Tang T; Zheng Y; Chen Z; Lin H; Ding C; Wang T; Chen H; Guo Y; Xu C; Zhou H; Wu X; Fu X; Yan F; Mao Z; Chen G.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ERα-negative tumor growth.
Fébrissy C; Adlanmerini M; Péqueux C; Boudou F; Buscato M; Gargaros A; Gilardi-Bresson S; Boriak K; Laurell H; Fontaine C; Katzenellenbogen BS; Katzenellenbogen JA; Guillermet-Guibert J; Arnal JF; Metivier R; Lenfant F.
Theranostics (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complement…
Richter S; Steenblock C; Fischer A; Lemm S; Ziegler CG; Bechmann N; Nölting S; Pietzsch J; Ullrich M.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Efficient 3D imaging and pathological analysis of the human lymphoma tumor microenvironment using light-sheet immunoflu…
Chen L; Meng J; Zhou Y; Zhao F; Ma Y; Feng W; Chen X; Jin J; Gao S; Liu J; Zhang M; Liu A; Hong Z; Tang J; Kuang D; Huang L; Zhang Y; Fei P.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Peptide receptor radionuclide therapy (PRRT) in metastatic neuroendocrine tumors of unknown primary (CUP-NETs).
Baum RP; Wang P; Jakobsson V; Zhao T; Schuchardt C; Khong PL; Zhang J.
Theranostics (Unknown)
Published: 2024
3/6 Transparent
Funding Declared